Manatuck Hill Partners’s Cytosorbents Corp CTSO Stock Holding History

Manatuck Hill Partners’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,250	Closed	-$966K	–	81
2020 Q1	$966K	Buy	+6,250	New	+$631K	0.89%	33
2019 Q1	–	Sell	-9,705	Closed	-$1.57M	–	97
2018 Q4	$1.57M	Sell	9,705 -5,460	-36%	-$1.08M	0.81%	43
2018 Q3	$3.91M	Buy	15,165 +2,255	+17%	+$565K	1.47%	25
2018 Q2	$2.94M	Buy	12,910 +600	+5%	+$114K	1.18%	26
2018 Q1	$1.74M	Buy	12,310 +3,630	+42%	+$549K	0.92%	30
2017 Q4	$1.13M	Buy	8,680 +1,180	+16%	+$150K	0.59%	42
2017 Q3	$930K	Buy	+7,500	New	+$764K	0.45%	46
2017 Q2	–	Sell	-7,750	Closed	-$698K	–	88
2017 Q1	$698K	Buy	7,750 +5,250	+210%	+$587K	0.3%	60
2016 Q4	$273K	Buy	+2,500	New	+$274K	0.13%	71

Other funds holding CTSO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Manatuck Hill Partners's CTSO Position: Q2 2020 in Review

Manatuck Hill Partners sold out of Cytosorbents Corp (CTSO) in Q2 2020, closing a stake of 6,250 shares — an estimated $966K sold.

Manatuck Hill Partners first reported a position in CTSO in Q4 2016 and held it in 9 quarters. The position peaked at $3.91M in Q3 2018. 90 funds tracked by Wall St. Rank hold CTSO as of Q2 2020.

Manatuck Hill Partners reported no remaining Cytosorbents Corp position as of Q2 2020 after selling out during the quarter.
Manatuck Hill Partners sold 6,250 Cytosorbents Corp shares in Q2 2020, an estimated $966K.
Manatuck Hill Partners first reported a position in Cytosorbents Corp in Q4 2016 and held it in 9 quarters.
Manatuck Hill Partners's Cytosorbents Corp position peaked at $3.91M in Q3 2018.
90 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2020.

Based on Manatuck Hill Partners's 13F filing for Q2 2020, filed 14 Aug 2020.